1676 Results for "

R/S

" in MedChemExpress (MCE) Product Catalog:
Products (1676)

1676 Results for "R/S" in MCE Product Catalog:

17
17 Cited Publications
Art. -Nr.: HY-18690
CAS. Nr.: 1446502-11-9
Synonyms: AG-221
Forschungsgebiete:  

Cancer

Enasidenib is an oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes, with IC50s of 100 and 400 nM against IDH2 R140Q and IDH2 R172K, respectively.
loading...
    loading...
14
14 Cited Publications
Art. -Nr.: HY-18627A
CAS. Nr.: 1627607-87-7
Synonyms: (R)-PFI-2 hydrochloride
PFI-2 ((R)-PFI-2 hydrochloride) hydrochloride is a potent and selective SET domain containing lysine methyltransferase 7 (SETD7) inhibitor. (R)-PFI-2 shows high inhibiting activity with IC50 value of 2.0  nM and (S)-PFI-2 shows inhibiting activity with IC50  value of 1.0  μM. PFI-2 hydrochloride can be used for the research of chronic kidney disease and inflammation response in the development of renal fibrosis .
loading...
    loading...
14
14 Cited Publications
Art. -Nr.: HY-18627
CAS. Nr.: 1627676-59-8
Synonyms: (R)-PFI-2
PFI-2 ((R)-PFI-2 hydrochloride) hydrochloride, a chemical probe, is a potent and selective SET domain containing lysine methyltransferase 7 (SETD7) inhibitor. (R)-PFI-2 shows high inhibiting activity with IC50 value of 2.0 nM and (S)-PFI-2 shows inhibiting activity with IC50 value of 1.0 μM. PFI-2 hydrochloride can be used for the research of chronic kidney disease and inflammation response in the development of renal fibrosis .
loading...
    loading...
13
13 Cited Publications
Art. -Nr.: HY-100944
CAS. Nr.: 6090-95-5
Reinheit:  99.92%
Target:  

Glycosidase

Forschungsgebiete:  

Neurological Disease

Conduritol B epoxide is an irreversible covalently bound acid β-glucosidase (GCase) inhibitor.
loading...
    loading...
13
13 Cited Publications
Art. -Nr.: HY-14258
CAS. Nr.: 128196-01-0
Reinheit:  99.98%
Synonyms: (S)-Citalopram; (S)-(+)-Citalopram
Target:  

Serotonin Transporter

Forschungsgebiete:  

Neurological Disease Cancer

Escitalopram ((S)-Citalopram), the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram has ~30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram is an antidepressant for the research of major depression .
loading...
    loading...
13
13 Cited Publications
Art. -Nr.: HY-14258A
CAS. Nr.: 219861-08-2
Reinheit:  99.88%
Synonyms: (S)-Citalopram oxalate; (S)-(+)-Citalopram oxalate
Target:  

Serotonin Transporter

Forschungsgebiete:  

Neurological Disease Cancer

Escitalopram ((S)-Citalopram) oxalate, the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram oxalate has ∼30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram oxalate is an antidepressant for the research of major depression .
loading...
    loading...
13
13 Cited Publications
Art. -Nr.: HY-18100A
CAS. Nr.: 75136-54-8
PRE-084 hydrochloride is a highly selective σ1 receptor (S1R) agonist, with an IC50 of 44 nM. PRE-084 hydrochloride exhibits good neuroprotective effects, can improve motor function and motor neuron survival in mice. PRE-084 hydrochloride also can ameliorate myocardial ischemia-reperfusion injury in rats by activating the Akt-eNOS pathway .
loading...
    loading...
12
12 Cited Publications
Art. -Nr.: HY-12026
CAS. Nr.: 1213269-23-8
Reinheit:  98.99%
Target:  

EGFR

Forschungsgebiete:  

Cancer

WZ4002 is a mutant selective EGFR inhibitor with IC50s of 2, 8, 3 and 2 nM for EGFR L858R, EGFR L858R/T790M, EGFR E746_A750 and EGFR E746_A750/T790M, respectively.
loading...
    loading...
12
12 Cited Publications
Art. -Nr.: HY-50905
CAS. Nr.: 405169-16-6
Synonyms: CHIR-258; TKI258
Target:  

FLT3 c-Kit FGFR VEGFR PDGFR c-Fms

Forschungsgebiete:  

Cancer

Dovitinib (CHIR-258) is an orally active, potent multi-targeted tyrosine kinase (RTK) inhibitor with IC50s of 1, 2, 36, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, CSF-1R, FGFR1/FGFR3, VEGFR1/VEGFR2/VEGFR3 and PDGFRα/PDGFRβ, respectively. Dovitinib has potent antitumor activity .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-13203
CAS. Nr.: 761437-28-9
Reinheit:  99.77%
Synonyms: TAE226
Forschungsgebiete:  

Endocrinology Cancer

NVP-TAE 226 (TAE226) is a potent and ATP-competitive dual FAK and IGF-1R inhibitor with IC50s of 5.5 nM and 140 nM, respectively. NVP-TAE 226 (TAE226) also effectively inhibits Pyk2 and insulin receptor (InsR) with IC50s of 3.5 nM and 44 nM, respectively .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-19834
CAS. Nr.: 1434048-34-6
Synonyms: GDC-0853
Target:  

Btk

Forschungsgebiete:  

Cancer

Fenebrutinib (GDC-0853) is a potent, selective, orally available, and noncovalent bruton's tyrosine kinase (Btk) inhibitor with Kis of 0.91 nM, 1.6, 1.3, 12.6, and 3.4 nM for WT Btk, and the C481S, C481R, T474I, T474M mutants. Fenebrutinib has the potential for rheumatoid arthritis and systemic lupus erythematosus research .
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-121203
CAS. Nr.: 59729-33-8
Reinheit:  99.76%
Target:  

Serotonin Transporter

Forschungsgebiete:  

Neurological Disease Cancer

Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission .
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-10588
CAS. Nr.: 71145-03-4
Reinheit:  99.96%
Synonyms: (±)-Bay K 8644
Target:  

Calcium Channel

Bay K 8644 ((±)-Bay K 8644) is a racemate consisting of two isomers (R)-(+)-Bay-K-8644 and (S)-(-)-Bay-K-8644 . Bay K 8644 is a L-type Ca 2+ channel agonist with an EC50 of 17.3 nM. Bay K 8644 increases Ca 2+ influx through sarcolemmal Ca 2+ channels by increasing the open time of the channel. Bay K 8644 has vasoconstrictive effects .
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-107608
CAS. Nr.: 71160-24-2
Reinheit:  ≥98.0%
Synonyms: LTB4; 5(S),12(R)-DiHETE
Leukotriene B4 (LTB4) is known as one of the most potent chemoattractants and activators of leukocytes and is involved in inflammatory diseases. Leukotriene B4 is also an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs .
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-14818
CAS. Nr.: 203120-17-6
Reinheit:  99.27%
Synonyms: R 125489
Target:  

Influenza Virus

Forschungsgebiete:  

Infection

Laninamivir (R 125489) is a potent influenza neuraminidase (NA) inhibitor with IC50s of 0.90 nM, 1.83 nM and 3.12 nM for avian H12N5 NA (N5), pH1N1 N1 NA (p09N1) and A/RI/5+/1957 H2N2 N2 (p57N2), respectively .
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-100742
CAS. Nr.: 1802977-61-2
Reinheit:  99.38%
GNE-140 racemate is a racemic mixture of (R)-GNE-140 (HY-100742A) and (S)-GNE-140 (HY-100742B), and also a tautomer of GNE-140 (HY-118241). GNE-140 racemate is an orally active lactate dehydrogenase inhibitor, with an IC50 of 3 nM against human LDHA and an IC50 of 5 nM against LDHB. GNE-140 racemate reduces the phosphorylation level and total protein expression of p38 MAPK, and inhibits EGF-induced AKT phosphorylation. GNE-140 racemate decreases lactate production, regulates glycolysis, the pentose phosphate pathway and nucleotide biosynthesis, increases extracellular pH, inhibits cell proliferation, migration and invasion, and induces caspase-3 activation and ROS accumulation. GNE-140 racemate can be used in research related to breast cancer, cystic fibrosis and pancreatic cancer .
loading...
    loading...
8
8 Cited Publications
Art. -Nr.: HY-15730
CAS. Nr.: 1092364-38-9
Reinheit:  99.96%
Synonyms: HM781-36B; NOV120101
Target:  

EGFR Apoptosis

Forschungsgebiete:  

Cancer

Poziotinib (HM781-36B) is an orally active, irreversible pan-HER inhibitor, which effectively inhibits EGFR wt, HER-2 and HER-4 with IC50s of 3.2, 5.3 and 23.5 nM, respectively. Poziotinib (HM781-36B) also shows excellent inhibitory activities against mutated EGFRs, including EGFR T790M and EGFR L858R/T790M, with IC50s of 4.2 and 2.2 nM, respectively. Excellent antitumor activity .
loading...
    loading...
8
8 Cited Publications
Art. -Nr.: HY-P80846
Synonyms: PIK3R1; GRB1; Phosphatidylinositol 3-kinase regulatory subunit alpha; PI3-kinase regulatory subunit alpha; PI3K regulatory subunit alpha; PtdIns-3-kinase regulatory subunit alpha; Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha; PI3-kinase s

Host:  

Rabbit

Application:  

WB, IHC-F, IHC-P, ICC/IF, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
7
7 Cited Publications
Art. -Nr.: HY-104042
CAS. Nr.: 1644545-52-7
Reinheit:  99.87%
Synonyms: AG-881
Forschungsgebiete:  

Cancer

Vorasidenib (AG-881) is an orally available, brain penetrant second-generation dual mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2) inhibitor. Vorasidenib (AG-881) exhibits nanomolar inhibition of (D)-2-hydroxyglutarate (D-2-HG), and the IC50 ranges of 0.04~22 nM against IDH1 R132C, IDH1 R132G, IDH1 R132H and IDH1 R132S and 7~14 nM against IDH2 R140Q and 130 nM against IDH2 R172K. Vorasidenib can be used for the study of grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1/2 mutation .
loading...
    loading...
7
7 Cited Publications
Art. -Nr.: HY-10524
CAS. Nr.: 1089283-49-7
Reinheit:  99.03%
Forschungsgebiete:  

Endocrinology Cancer

GSK1904529A is a potent, selective, orally active, and ATP-competitive inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR), with IC50s of 27 and 25 nM, respectively. GSK1904529A shows poor activity (IC50>1 μM) in 45 other serine/threonine and tyrosine kinases. GSK1904529A exhibits anti-tumor activity .
loading...
    loading...